US2005197281A1PendingUtilityA1
Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
Priority: Jun 21, 1997Filed: Mar 28, 2005Published: Sep 8, 2005
Est. expiryJun 21, 2017(expired)· nominal 20-yr term from priority
A61P 43/00A61P 7/06A61K 38/42
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A kit comprising an erythropoietin and a modified hemoglobin is disclosed.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical kit comprising:
(a) an erythropoietin preparation that provides active erythropoietin in an amount of from about 3,000 U to about 7000 U, and (b) a preparation containing from about 50 ml to about 100 ml of at least one modified hemoglobin so as to correspond to from about 100 mg to about 200 mg of Fe 2++ ; the erythropoietin preparation and the modified hemoglobin preparation being packaged in either a single container or two separate containers.
2 . The kit of claim 15 , wherein the erythropoietin preparation and the modified hemoglobin preparation are each present in separate containers and in different forms of administration.
3 . The kit of claim 16 wherein the forms for administration are selected from forms for injection and for infusion.Join the waitlist — get patent alerts
Track US2005197281A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.